WELCOME SUMMIT 2024
We look forward to welcoming you to the 8th annual U.S E-Cigarette Summit, which will take place in Washington D.C. on May 14, 2024. Joining Instructions will be sent on May 10 to all registered delegates and can also be viewed on the Hybrid Access page on this website.
The 2024 E-Cigarette Summit marks 60 years since the publication of U.S Surgeon General Luther Terry’s landmark report on smoking and health – a consensus document that unequivocally established the link between smoking and serious disease. Viewed as the catalyst for the modern-day tobacco control movement, the 1964 report remains a historic example of the importance of science-led public health action.
The role of non-combustible alternatives to the cigarette is a variable that Surgeon General Terry and his committee did not have to address. Determining whether and how to integrate such products into the fight against smoking-related death and disease is the task of public health and tobacco control experts of today. In this 60th Anniversary year, it is hoped that the 2024 Summit will embody the spirit of the 1964 report that placed scientific evidence at the forefront of public health action.
The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the independent scientific evidence to support policy and regulatory decisions. U.S. smoking rates for both adults and youth have declined tremendously over the last 60 years, but of the 30 million Americans who still smoke today, it is those who are less privileged that bear the brunt of smoking-related deaths and diseases. Much work remains to be done, if we are to achieve a smoke-free society for all, we hope that you can join us at the Summit in May.
WE ARE HYBRID
The E-Cigarette Summit is hybrid and offers live and on-demand viewing option for those who are unable to join us in person. We aim to maximise the experience for everyone and all Summit participants will have access to the event app where they can view the Speaker slides, submit and answer questions and participate in the active chat/discussion.
We will “live stream” the Summit as per the agenda (US EST) Individual videos of speaker presentations and the panel discussions will be added to the virtual platform within 48 hours of the live event for you to watch/re-watch later. The app will be live for 3 months after the event.
SUMMIT CHAIRS 2024
SUMMIT CHAIR
Prof Thomas J. Glynn
Prof Thomas J. Glynn
Adjunct Lecturer, Stanford Prevention Research Center
Stanford University School of Medicine
SUMMIT CHAIR
Prof Robin J. Mermelstein, PhD
Prof Robin J. Mermelstein, PhD
Distinguished Professor of Psychology and IHRP Director
University of Illinois, Chicago
CONFIRMED SUMMIT SPEAKERS 2024
Associate Prof Abigail Friedman
Associate Professor
Dept of Health Policy & Management, Yale School of Public Health
Dr. Nancy A. Rigotti, MD
Professor of Medicine, Harvard Medical School
Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston
Professor Ann McNeill
Professor of Tobacco Addiction
Institute of Psychiatry, Psychology & Neuroscience, Kings College London
Prof Mike Cummings
Professor, Dep't Psychiatry & Behavioural Sciences
Medical University of South Carolina
Prof Benjamin A. Toll
Professor of Public Health Sciences & Psychiatry
Medical University of South Carolina
Prof Scott Sherman
Professor of Population Health, Medicine and Psychiatry
NYU Grossman School of Medicine
Assoc Prof Andrea Villanti
Associate professor in the Department of Health Behavior, Society, and Policy
Rutgers School of Public Health
Ruoyan Sun
Assistant Professor, Department of Health Policy & Organization
School of Public Health, University of Alabama at Birmingham
Prof Kenneth E. Warner
Avedis Donabedian Distinguished University Professor Emeritus and Dean Emeritus
School of Public Health, University of Michigan
Prof Thomas J. Glynn, PhD
Adjunct Lecturer
Stanford Prevention Research Centre, Stanford University School of Medicine
Mitch Zeller J.D
Retired Director, Center for Tobacco Products (CTP)
The Food & Drug Administration (FDA)
Martin Dockrell
Tobacco Control Programme Lead
The Office of Health Improvement and Disparities (OHID), UK
Prof Neal L. Benowitz MD
Professor of Medicine Emeritus (Active)
University of California, San Franciso
Prof Robin Mermelstein
Distinguished Professor of Psychology and IHRP Director
University of Illinois, Chicago
Dr Jamie Hartmann-Boyce
Assistant Professor in Health Promotion and Policy
University of Massachusetts Amherst
WHAT QUESTIONS WILL BE EXPLORED?
The E-Cigarette Summit provides an evidence based environment that encourages open and respectful dialogue on the key science and current public health topics. The format includes high level briefings from global experts followed by panel discussions and audience Q&A.
- If vaping Is a gateway to cigarette smoking, what are the implications?
- Past and future trends in nicotine-delivery product use
- Effects of reduced-risk nicotine products on smoking prevalence and cigarette sales
- Flavored nicotine product sales restrictions in the US: Policy variations and impacts
- Are e-cigarettes less addictive than cigarettes – why does it matter?
- E-Cigarettes and smoking cessation – understanding the data
- Evidence, emotions and philosophy – why all are important in tobacco control policy
- The key differences and similarities of vaporized cannabis versus nicotine
- Risk perception of e-cigarettes and vaping – the role of health communication
- Interactions between cannabis and nicotine use
- Policy comparisons between the US, Canada, UK and New Zealand – Who is doing what and why.
- What doctors say…and what patients hear – should e-cigarettes be recommended for smoking cessation?
- What can we learn from historical events and US per-capita cigarette data from 1984 to present?
- E-cigarettes and mental health disorders: Opportunity or concern?
- What constitutes success? A dialogue on the “end state”
WHO SHOULD ATTEND
The E-Cigarette Summit is particularly relevant to:
- Regulators and policy advisors
- Health providers and public health advocates
- National, state and local legislators and their staffs
- Public health professionals
- Scientific/research community
- Medical and health professionals
- e-cigarette industry stakeholders
WHO SHOULD ATTEND
- Regulators and policy advisors
- Health providers and public health advocates
- National, state and local legislators and their staffs
- Public health professionals
- Scientific/research community
- Medical and health professionals
- e-cigarette industry stakeholders